In the same regard, a previous report by Strekalova et al. [19] revealed the efficacy of COX-2 inhibition with celecoxib in ameliorating depression-linked anhedonia in a chronic mild stress paradigm in mice. This evidence concerns the gene PTGS2 and depressive symptom measurement.